Cargando…
Microbiome-Related and Infection Control Approaches to Primary and Secondary Prevention of Clostridioides difficile Infections
Clostridioides difficile infections (CDIs) have decreased in the past years, but since 2021, some hospitals have reported an increase in CDI rates. CDI remains a global concern and has been identified as an urgent threat to healthcare. Although multiple treatment options are available, prevention st...
Autores principales: | McFarland, Lynne V., Goldstein, Ellie J. C., Kullar, Ravina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303462/ https://www.ncbi.nlm.nih.gov/pubmed/37375036 http://dx.doi.org/10.3390/microorganisms11061534 |
Ejemplares similares
-
Investigational Treatment Agents for Recurrent Clostridioides difficile Infection (rCDI)
por: Kullar, Ravina, et al.
Publicado: (2020) -
Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review
por: McFarland, Lynne V.
Publicado: (2015) -
Potential Roles for Probiotics in the Treatment of COVID-19 Patients and Prevention of Complications Associated with Increased Antibiotic Use
por: Kullar, Ravina, et al.
Publicado: (2021) -
Lactobacillus Bacteremia and Probiotics: A Review
por: Kullar, Ravina, et al.
Publicado: (2023) -
Why Do ACG and AGA Guidelines Differ for the Use of Probiotics and the Prevention of CDI?
por: McFarland, Lynne V., et al.
Publicado: (2022)